嗜酸性粒细胞髓系增生性疾病。
Eosinophilic myeloproliferative disorders.
机构信息
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
出版信息
Hematology Am Soc Hematol Educ Program. 2011;2011:257-63. doi: 10.1182/asheducation-2011.1.257.
Abstract
Despite recent attempts to define and classify patients with marked eosinophilia and features consistent with myeloproliferative disease, areas of controversy remain. These are particularly apparent in situations in which multiple lineages are involved in a clonal process and clinical manifestations are overlapping. Although the introduction of new molecular diagnostics and targeted therapies has begun to clarify the boundaries between some of these disorders, several questions remain with respect to the classification of patients with myeloproliferative hypereosinophilic syndrome (HES) of unknown etiology.
摘要
尽管最近有人试图对伴有明显嗜酸性粒细胞增多和骨髓增殖性疾病特征的患者进行定义和分类，但仍存在一些争议领域。在涉及多个谱系的克隆过程和临床表现重叠的情况下，这些问题尤其明显。尽管新的分子诊断和靶向治疗的引入开始澄清其中一些疾病之间的界限，但对于病因不明的骨髓增殖性高嗜酸性粒细胞综合征（HES）患者的分类，仍存在一些问题。
相似文献
1
Eosinophilic myeloproliferative disorders.嗜酸性粒细胞髓系增生性疾病。
Hematology Am Soc Hematol Educ Program. 2011;2011:257-63. doi: 10.1182/asheducation-2011.1.257.
2
Eosinophilic myeloid disorders.嗜酸性粒细胞髓系疾病。
Semin Hematol. 2012 Apr;49(2):120-7. doi: 10.1053/j.seminhematol.2012.01.008.
3
Molecular classification and pathogenesis of eosinophilic disorders: 2005 update.嗜酸性粒细胞增多症的分子分类与发病机制：2005年更新版
Acta Haematol. 2005;114(1):7-25. doi: 10.1159/000085559.
4
Primary eosinophilic disorders: a concise review.原发性嗜酸性粒细胞疾病：简要综述。
Curr Hematol Malig Rep. 2008 Jan;3(1):37-43. doi: 10.1007/s11899-008-0007-9.
5
Myeloid neoplasms with eosinophilia.伴嗜酸性粒细胞增多的髓系肿瘤。
Blood. 2017 Feb 9;129(6):704-714. doi: 10.1182/blood-2016-10-695973. Epub 2016 Dec 27.
6
KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities.伴有嗜酸性粒细胞增多的KIT D816V相关系统性肥大细胞增多症和FIP1L1/PDGFRA相关慢性嗜酸性粒细胞白血病是不同的疾病实体。
J Allergy Clin Immunol. 2007 Sep;120(3):680-7. doi: 10.1016/j.jaci.2007.05.024. Epub 2007 Jul 12.
7
Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders.伊马替尼治疗高嗜酸性粒细胞综合征及嗜酸性粒细胞增多相关的骨髓增殖性疾病。
Leuk Res. 2004 May;28 Suppl 1:S47-52. doi: 10.1016/j.leukres.2003.10.006.
8
Idiopathic Hypereosinophilic Syndrome With Cutaneous Manifestations and Flame Figures: A Spectrum of Eosinophilic Dermatoses Whose Features Overlap With Wells' Syndrome.伴有皮肤表现和火焰状图形的特发性高嗜酸性粒细胞综合征：一组嗜酸性粒细胞性皮肤病，其特征与韦尔斯综合征重叠。
Am J Dermatopathol. 2015 Dec;37(12):910-4. doi: 10.1097/DAD.0000000000000279.
9
Modern diagnosis and treatment of primary eosinophilia.原发性嗜酸性粒细胞增多症的现代诊断与治疗
Acta Haematol. 2005;114(1):52-60. doi: 10.1159/000085562.
10
FIP1L1/PDGFR alpha-associated systemic mastocytosis.FIP1L1/PDGFRα 相关性系统性肥大细胞增生症。
Int Arch Allergy Immunol. 2010;152 Suppl 1(Suppl 1):101-5. doi: 10.1159/000312134. Epub 2010 Jun 4.
引用本文的文献
1
Four challenging cases of eosinophilic endocarditis or myocarditis with literature review.四例具有挑战性的嗜酸性粒细胞性心内膜炎或心肌炎病例并文献综述
J Cardiothorac Surg. 2025 May 27;20(1):241. doi: 10.1186/s13019-025-03496-6.
2
Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes.嗜酸性粒细胞增多症和嗜酸性粒细胞增多综合征的分子发病机制和治疗观点。
Int J Mol Sci. 2021 Jan 6;22(2):486. doi: 10.3390/ijms22020486.
3
A case report of Löffler endocarditis in idiopathic hypereosinophilic syndrome: recovery is possible.特发性嗜酸性粒细胞增多综合征中Löffler心内膜炎的一例病例报告：恢复是可能的。
Eur Heart J Case Rep. 2018 Mar 13;2(2):yty030. doi: 10.1093/ehjcr/yty030. eCollection 2018 Jun.
4
Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells.利用 Siglec-8 内吞机制杀死人嗜酸性粒细胞和恶性肥大细胞。
J Allergy Clin Immunol. 2018 May;141(5):1774-1785.e7. doi: 10.1016/j.jaci.2017.06.028. Epub 2017 Jul 20.
5
Spinal Myeloid Sarcoma "Chloroma" Presenting as Cervical Radiculopathy: Case Report.脊髓髓性肉瘤“绿色瘤”表现为颈椎病根病变：病例报告。
Global Spine J. 2015 Jun;5(3):241-6. doi: 10.1055/s-0035-1549433.
6
Is this still just sarcoidosis, or should we a-DRESS a different diagnosis?这仍然只是结节病，还是我们应该考虑另一种诊断？
BMJ Case Rep. 2015 Jun 29;2015:bcr2014207778. doi: 10.1136/bcr-2014-207778.
7
Chronic Eosinophilic Leukemia-Not Otherwise Specified (NOS) in the Background of a Large Cell Lymphoma.大细胞淋巴瘤背景下的慢性嗜酸性粒细胞白血病，未另行指定（NOS）
Case Rep Hematol. 2013;2013:458303. doi: 10.1155/2013/458303. Epub 2013 Oct 9.
8
Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophilia.伴有嗜酸性粒细胞增多的骨髓增殖性疾病的当前分类、分子改变及酪氨酸激酶抑制剂治疗的综述
J Blood Med. 2013 Aug 9;4:111-21. doi: 10.2147/JBM.S33142. eCollection 2013.
9
Targeting self-renewal pathways in myeloid malignancies.靶向髓系恶性肿瘤的自我更新途径。
Cell Commun Signal. 2013 May 15;11(1):33. doi: 10.1186/1478-811X-11-33.
本文引用的文献
1
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib.一例伴有外显子 9 KIT 突变的肥大细胞白血病和对伊马替尼良好反应的病例。
Eur J Haematol. 2011 Jun;86(6):531-5. doi: 10.1111/j.1600-0609.2011.01598.x. Epub 2011 Apr 7.
2
Concomitant FIP1L1-PDGFRA fusion gene and T-cell clonality in a case of chronic eosinophilic leukemia with clonal evolution and an incomplete response to imatinib.一例慢性嗜酸性粒细胞白血病伴克隆进化且对伊马替尼反应不完全患者中FIP1L1-PDGFRA融合基因与T细胞克隆性并存的情况
Leuk Lymphoma. 2011 Feb;52(2):335-8. doi: 10.3109/10428194.2010.534210.
3
Novel imatinib-sensitive PDGFRA-activating point mutations in hypereosinophilic syndrome induce growth factor independence and leukemia-like disease.新型伊马替尼敏感的血小板衍生生长因子受体 A 激活点突变导致嗜酸性粒细胞增多综合征中的生长因子独立性和类白血病疾病。
Blood. 2011 Mar 10;117(10):2935-43. doi: 10.1182/blood-2010-05-286757. Epub 2011 Jan 11.
4
A prospective evaluation of cardiac function in patients with chronic myeloid leukaemia treated with imatinib.前瞻性评估伊马替尼治疗慢性髓性白血病患者的心脏功能。
Leuk Res. 2011 Jan;35(1):49-51. doi: 10.1016/j.leukres.2010.08.020. Epub 2010 Oct 27.
5
The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitro.髓系肿瘤中 PDGFRA 异常患者对 PDGFR 抑制剂的临床耐药频率较低，这可能与体外可能出现的 PDGFRA 激酶结构域突变有限有关。
Oncogene. 2011 Feb 24;30(8):933-43. doi: 10.1038/onc.2010.476. Epub 2010 Oct 25.
6
Incidence of myeloproliferative hypereosinophilic syndrome in the United States and an estimate of all hypereosinophilic syndrome incidence.美国骨髓增殖性高嗜酸性粒细胞综合征的发病率及所有高嗜酸性粒细胞综合征发病率的估计值。
J Allergy Clin Immunol. 2010 Jul;126(1):179-81. doi: 10.1016/j.jaci.2010.03.035.
7
Refining the definition of hypereosinophilic syndrome.细化嗜酸性粒细胞增多综合征的定义。
J Allergy Clin Immunol. 2010 Jul;126(1):45-9. doi: 10.1016/j.jaci.2010.03.042.
8
Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.伴显著嗜酸性粒细胞增多和 PDGFRA 重排的髓系肿瘤，用甲磺酸伊马替尼治疗。
Pediatr Blood Cancer. 2010 Oct;55(4):730-2. doi: 10.1002/pbc.22655.
9
Successful treatment of imatinib-resistant hypereosinophilic syndrome with nilotinib.尼洛替尼成功治疗伊马替尼耐药的高嗜酸性粒细胞综合征
Leuk Res. 2010 Aug;34(8):e200-1. doi: 10.1016/j.leukres.2010.02.024. Epub 2010 Mar 29.
10
Hypereosinophilic syndrome: a multicenter, retrospective analysis of clinical characteristics and response to therapy.嗜酸性粒细胞增多综合征：一项多中心回顾性分析临床特征和治疗反应。
J Allergy Clin Immunol. 2009 Dec;124(6):1319-25.e3. doi: 10.1016/j.jaci.2009.09.022.
Zotero 插件